GNGT1 and medulloblastoma: Some studies found that GNGT1 may be used as a biomarker of medulloblastoma, and its mutation may be related to neuroautoimmune diseases, such as multiple sclerosis [33,34], providing a new angle to evaluate the inherited causes of neurodegeneration.